These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15726563)

  • 1. Molecular apple peels.
    Garric J; Léger JM; Huc I
    Angew Chem Int Ed Engl; 2005 Mar; 44(13):1954-8. PubMed ID: 15726563
    [No Abstract]   [Full Text] [Related]  

  • 2. Catalysis in aqueous media for the synthesis of drug-like molecules.
    Lombardo M; Trombini C
    Curr Opin Drug Discov Devel; 2010; 13(6):717-32. PubMed ID: 21061233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Boron reagents in process chemistry: Excellent tools for selective reductions.
    Burkhardt ER; Matos K
    Chem Rev; 2006 Jul; 106(7):2617-50. PubMed ID: 16836295
    [No Abstract]   [Full Text] [Related]  

  • 4. Encapsulating the right chemistry.
    Trivedi B
    Nat Biotechnol; 1999 Apr; 17(4):339-41. PubMed ID: 10207880
    [No Abstract]   [Full Text] [Related]  

  • 5. Reactions in unusual media.
    Clarke D; Ali MA; Clifford AA; Parratt A; Rose P; Schwinn D; Bannwarth W; Rayner CM
    Curr Top Med Chem; 2004; 4(7):729-71. PubMed ID: 15032685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asymmetric synthesis of active pharmaceutical ingredients.
    Farina V; Reeves JT; Senanayake CH; Song JJ
    Chem Rev; 2006 Jul; 106(7):2734-93. PubMed ID: 16836298
    [No Abstract]   [Full Text] [Related]  

  • 7. Biocatalysis for pharmaceutical intermediates: the future is now.
    Pollard DJ; Woodley JM
    Trends Biotechnol; 2007 Feb; 25(2):66-73. PubMed ID: 17184862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinguishing anhydrous and hydrous forms of an active pharmaceutical ingredient in a tablet formulation using solid-state NMR spectroscopy.
    Griffin JM; Martin DR; Brown SP
    Angew Chem Int Ed Engl; 2007; 46(42):8036-8. PubMed ID: 17847137
    [No Abstract]   [Full Text] [Related]  

  • 9. On the antibiotic activity of oxazolomycin.
    Bagwell CL; Moloney MG; Thompson AL
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4081-6. PubMed ID: 18558487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of drug intermediates by using direct organocatalytic multi-component reactions.
    Ramachary DB; Kishor M; Reddy GB
    Org Biomol Chem; 2006 May; 4(9):1641-6. PubMed ID: 16633553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organolithium reagents in pharmaceutical asymmetric processes.
    Wu G; Huang M
    Chem Rev; 2006 Jul; 106(7):2596-616. PubMed ID: 16836294
    [No Abstract]   [Full Text] [Related]  

  • 12. Ozonolysis applications in drug synthesis.
    Van Ornum SG; Champeau RM; Pariza R
    Chem Rev; 2006 Jul; 106(7):2990-3001. PubMed ID: 16836306
    [No Abstract]   [Full Text] [Related]  

  • 13. Hydrogen bonding in ortho-substituted arylamides: the influence of protic solvents.
    Liu Z; Remsing RC; Liu D; Moyna G; Pophristic V
    J Phys Chem B; 2009 May; 113(20):7041-4. PubMed ID: 19397255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New opportunities for biocatalysis: making pharmaceutical processes greener.
    Woodley JM
    Trends Biotechnol; 2008 Jun; 26(6):321-7. PubMed ID: 18436317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMR studies of organic polymorphs and solvates.
    Harris RK
    Analyst; 2006 Mar; 131(3):351-73. PubMed ID: 16496044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triangular assembly through charged hydrogen bonds in polar solvent.
    Lee HY; Moon D; Lah MS; Hong JI
    J Org Chem; 2006 Nov; 71(24):9225-8. PubMed ID: 17109553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerating the drug-discovery process: new tools and technologies available to medicinal chemists.
    Raveglia LF; Giardina GA
    Future Med Chem; 2009 Sep; 1(6):1019-23. PubMed ID: 21425990
    [No Abstract]   [Full Text] [Related]  

  • 18. Foldamers with unusual structural architecture from spirobi(indane) building blocks.
    Kendhale AM; Gonnade R; Rajamohanan PR; Hofmann HJ; Sanjayan GJ
    Chem Commun (Camb); 2008 Jun; (22):2541-3. PubMed ID: 18506237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QSRR: quantitative structure-(chromatographic) retention relationships.
    Kaliszan R
    Chem Rev; 2007 Jul; 107(7):3212-46. PubMed ID: 17595149
    [No Abstract]   [Full Text] [Related]  

  • 20. Applications of combinatorial technologies to drug discovery. 2. Combinatorial organic synthesis, library screening strategies, and future directions.
    Gordon EM; Barrett RW; Dower WJ; Fodor SP; Gallop MA
    J Med Chem; 1994 May; 37(10):1385-401. PubMed ID: 8182695
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.